GLP-1 pills are coming, and they could revolutionize weight-loss
WEBSep 17, 2024 · Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. But she and other doctors also warn about the potential for misuse, a...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
WEBThe drug contains the GLP-1 hormone, a key ingredient in Ozempic and Wegovy, in addition to glucagon. Altimmune released data from a phase 2 trial of 391 adults with obesity or who are...
Popular weight-loss and diabetes medications linked to lower risk …
WEBJul 5, 2024 · CNN — GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests. People who are overweight or obese have a higher risk of getting 13 types...
FDA clarifies policies for compounders as national GLP-1 supply …
WEB4 days ago · Linkedin. [10/02/2024] The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide ...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBThe FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
WEBOct 30, 2023 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
WEBAug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
FDA approves first oral GLP-1 treatment for type 2 diabetes
WEBThe U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise.
Research shows GLP-1 drugs are effective but complex
WEBMay 30, 2024 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
MHRA approves GLP –1 receptor agonist semaglutide to reduce …
WEBJul 23, 2024 · This medicine, a GLP-1 receptor agonist, was already approved for use in the treatment of obesity and for weight management, to be used alongside diet, physical activity and behavioural support ...